- 询价
- MedChemExpress(MCE)
- 美国
- HY-N10693
- 2025年12月05日
企业认证
相关产品推荐更多 >
![Dibenzo[b,e][1,4]dioxin-d8,69699-83-8](https://img1.dxycdn.com/p/s14/2025/1205/453/4870510878871686991.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Please store the product under the recommended conditions in the Certificate of Analysis.
- 库存：
货期：询盘
- 供应商：
MedChemExpress LLC
- CAS号：
163559-04-4
- 规格：
询盘
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
Protoapigenin 4′-O-β-D-glucoside
CAS No. : 163559-04-4
MCE 国际站：Protoapigenin 4′-O-β-D-glucoside
产品活性：Protoapigenin 4'-O-β-D-glucoside 是一种黄酮苷，可从 Thelypteris torresiana中分离得到。
研究领域：Others
作用靶点：Others
相关产品：Digitonin | 5-Ph-IAA | FLAG peptide | Tocofersolan | Monocrotaline | Lactate sodium | TCEP hydrochloride | 3X FLAG peptide | DPPH | Pertussis Toxin | Pronase E (Activity ≥ 7000 U/g) | O-Propargyl-Puromycin | NMDI14 | Phytohemagglutinin | MYLS22 | Hyaluronidase | Biotinyl tyramide | Kifunensine | Human IgG1 kappa, Isotype Control | 4-Azido-L-phenylalanine | 6-Aminonicotinamide | Ammonium tetrathiomolybdate(VI) | OVA Peptide(257-264) TFA | Alkyne-phenol | Lauryl maltose neopentyl glycol | SHIN1 | CHAPS | Cytosporone B
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Synthesis of Azido-Functionalized Carbohydrates for the Design of Glycoconjugates
2,3,6,2′,3′,4′,6′-hepta-O -acetyl-β-d -lactoside. These molecules can then be used in the construction of glycoconjugates to find applications in chemical biology.
. Fig. 5.1. Inhibition of GSK-3 activity. A Depletion of both GSK-3α and GSK-3β is required for a decrease of β-catenin phosphorylationat Ser33/37. Panc04.03 cells were transfected with shControl, shGSK-3α, and shGSK-3β vectors, as describedin
Angiogenic Vessel-Targeting DDS by Liposomalized Oligopeptides
, (2) Therapeutic efficacy of adriamycin encapsulated in APRPG–PEG-modified liposomes, (3) Preparation of 5′-O -dipalmitoylphosphatidyl 2′-C -cyano-2′-deoxy-1-β-D-arabino -pentofuranosylcytosine (DPP–CNDAC) liposomes modified with APRPG–PEG, and (4) Therapeutic
技术资料暂无技术资料 索取技术资料
